AceRNA ^Companies

AceRNA is a biotech startup that specializes in the development of patient-centric genetic therapies. Their goal is to develop novel therapies that target only the cells causing a disease, minimizing patient burden. They contribute to regenerative medicine and drug discovery through the discovery of novel miRNA functions. AceRNA has recently entered into a collaboration with Pfizer to engineer RNA switches for potential targeted mRNA medicines. Their innovative approach and partnerships with other companies position them as a key player in the future of targeted medicine.